Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients

Simple item page
dc.contributor.advisorFolb, Peter Ien_ZA
dc.contributor.advisorLittle, Francescaen_ZA
dc.contributor.advisorSmith, Peteen_ZA
dc.contributor.authorMcIlleron, Helenen_ZA
dc.date.accessioned2014-07-28T18:19:12Z
dc.date.available2014-07-28T18:19:12Z
dc.date.issued2004en_ZA
dc.descriptionIncludes bibliographical references (leaves 190-203).
dc.description.abstractA prospectlve pharmacokinetic study was conducted amongst a cohort of 142 patients with tuberculosis (TB) susceptible to rifampicin and isoniazid at Brewelsleloof Hospital, Worcester, in the Western Cape.en_ZA
dc.identifier.apacitationMcIlleron, H. (2004). <i>Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Pharmacology. Retrieved from http://hdl.handle.net/11427/3290en_ZA
dc.identifier.chicagocitationMcIlleron, Helen. <i>"Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Pharmacology, 2004. http://hdl.handle.net/11427/3290en_ZA
dc.identifier.citationMcIlleron, H. 2004. Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - McIlleron, Helen AB - A prospectlve pharmacokinetic study was conducted amongst a cohort of 142 patients with tuberculosis (TB) susceptible to rifampicin and isoniazid at Brewelsleloof Hospital, Worcester, in the Western Cape. DA - 2004 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2004 T1 - Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients TI - Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients UR - http://hdl.handle.net/11427/3290 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/3290
dc.identifier.vancouvercitationMcIlleron H. Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Pharmacology, 2004 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/3290en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentDivision of Clinical Pharmacologyen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherPharmacologyen_ZA
dc.titleDeterminants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patientsen_ZA
dc.typeDoctoral Thesis
dc.type.qualificationlevelDoctoral
dc.type.qualificationnamePhDen_ZA
uct.type.filetypeText
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2004_mcllleron_h.pdf
Size:
30.15 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
PhD / Doctoral